Asset Allocation

As of January 31, 2026.
Type % Net
Cash 78.30%
Stock 20.14%
Bond 1.44%
Convertible 0.00%
Preferred 0.00%
Other 0.12%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.20%    % Emerging Markets: -0.25%    % Unidentified Markets: 2.06%

Americas 91.23%
91.37%
Canada 3.53%
United States 87.84%
-0.14%
As of January 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 8.00%
United Kingdom 2.25%
4.70%
Denmark 0.06%
France 1.87%
Germany 1.32%
Ireland 1.08%
Norway 0.00%
Sweden 0.66%
Switzerland -0.36%
0.00%
1.05%
Israel 1.05%
Greater Asia -1.29%
Japan -0.01%
0.76%
Australia 0.76%
-2.03%
Singapore -2.03%
0.00%
Unidentified Region 2.06%

Bond Credit Quality Exposure

AAA 0.00%
AA 70.34%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 29.66%
Short Term 0.00%
As of January 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
65.01%
Materials
62.52%
Consumer Discretionary
13.21%
Financials
-10.77%
Real Estate
0.05%
Sensitive
-48.47%
Communication Services
23.37%
Energy
5.28%
Industrials
-31.31%
Information Technology
-45.81%
Defensive
69.88%
Consumer Staples
33.98%
Health Care
38.58%
Utilities
-2.69%
Not Classified
13.59%
Non Classified Equity
0.06%
Not Classified - Non Equity
13.53%
As of January 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of January 31, 2026
Type % Net
Government 100.0%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
78.28%
Less than 1 Year
78.28%
Intermediate
21.72%
1 to 3 Years
21.72%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of January 31, 2026
View Bond Maturity Exposure
Start Trial